Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 22, 2023

Effect of Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Circulation 2023 Jun 25;[EPub Ahead of Print], SD Solomon, CJ Lowenstein, AS Bhatt, A Peikert, O Vardeny, MN Kosiborod, JS Berger, HR Reynolds, S Mavromichalis, A Barytol, AD Althouse, JF Luther, ES Leifer, AL Kindzelski, M Cushman, MN Gong, LZ Kornblith, P Khatri, KS Kim, L Baumann Kreuziger, L Wahid, BA Kirwan, MW Geraci, MD Neal, JS Hochman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading